FilingReader Intelligence

Cosmos Pharmaceutical boosts profit amid expansion, stock split impact

April 14, 2025 at 12:04 PM UTCBy FilingReader AI

Cosmos Pharmaceutical Corporation (TSE:3349) announced robust financial results for the third quarter of the fiscal year ending May 2025. Net sales increased 5.2% year-on-year to JPY752.268 billion, with operating profit surging 33.2% to JPY31.627 billion and profit attributable to owners of parent increasing 28.7% to JPY22.343 billion. The company attributed this growth to its continued strategy of low-cost operations and aggressive store expansion, opening 81 new locations while closing one.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Cosmos Pharmaceutical Corporation publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →